BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND STRN, ENSG00000115808, 6801, O43815, SG2NA, MGC125642
21 results:

  • 1. Reticular Myxoid Odontogenic Neoplasm with Novel strn::ALK Fusion: Report of 2 Cases in 3-Year-Old Males.
    Rosebush MS; Smith MH; Cordell KG; Callahan N; Zaid W; Gagan J; Bishop JA
    Head Neck Pathol; 2024 Mar; 18(1):26. PubMed ID: 38526831
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular Genetics of Diffuse Sclerosing Papillary Thyroid cancer.
    Alswailem M; Alghamdi B; Alotaibi A; Aljomiah A; Al-Hindi H; Murugan AK; Abouelhoda M; Shi Y; Alzahrani AS
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e704-e711. PubMed ID: 36995892
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhibition of ALK-Signaling Overcomes strn-ALK-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in Thyroid Cells.
    Nikitski AV; Condello V; Divakaran SS; Nikiforov YE
    Thyroid; 2023 Apr; 33(4):464-473. PubMed ID: 36585857
    [No Abstract]    [Full Text] [Related]  

  • 4. Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.
    Newfield RS; Jiang W; Sugganth DX; Hantash FM; Lee E; Newbury RO
    Int J Pediatr Otorhinolaryngol; 2022 Jun; 157():111121. PubMed ID: 35397361
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Frankly Invasive Carcinoma Ex-intraductal Carcinoma: Expanding on an Emerging and Perplexing Concept in Salivary Gland Tumor Pathology.
    McLean-Holden AC; Rooper LM; Lubin DJ; Magliocca KR; Manucha V; Sadow PM; Tobias J; Vargo RJ; Thompson LDR; Heidarian A; Weinreb I; Wenig B; Gagan J; Hernandez-Prera JC; Bishop JA
    Head Neck Pathol; 2022 Sep; 16(3):657-669. PubMed ID: 34985683
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma.
    Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD
    Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature Review.
    Agaimy A; Baněčková M; Ihrler S; Mueller SK; Franchi A; Hartmann A; Stoehr R; Skálová A
    Am J Surg Pathol; 2021 Sep; 45(9):1166-1178. PubMed ID: 33871952
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Detection of strn-ALK fusion in thyroid nodules with indeterminate cytopathology facilitates papillary thyroid cancer diagnosis.
    Jurkiewicz M; Cimic A; Murty VV; Kuo JH; Hsiao S; Fazlollahi L; Fernandes H
    Diagn Cytopathol; 2021 Apr; 49(4):E146-E151. PubMed ID: 33085842
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The Clinicopathological Results of Thyroid cancer With BRAFV600E Mutation in the Young Population of Fukushima.
    Iwadate M; Mitsutake N; Matsuse M; Fukushima T; Suzuki S; Matsumoto Y; Ookouchi C; Mizunuma H; Nakamura I; Nakano K; Sakamoto A; Hirokawa M; Ito M; Naganuma H; Hashimoto Y; Shimura H; Yamashita S; Suzuki S
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32827026
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
    Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
    Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Salivary Intraductal Carcinoma Arising within Intraparotid Lymph Node: A Report of 4 Cases with Identification of a Novel strn-ALK Fusion.
    Rooper LM; Thompson LDR; Gagan J; Oliai BR; Weinreb I; Bishop JA
    Head Neck Pathol; 2021 Mar; 15(1):179-185. PubMed ID: 32661669
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Characterization of thyroid cancer driven by known and novel ALK fusions.
    Panebianco F; Nikitski AV; Nikiforova MN; Kaya C; Yip L; Condello V; Wald AI; Nikiforov YE; Chiosea SI
    Endocr Relat Cancer; 2019 Nov; 26(11):803-814. PubMed ID: 31539879
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anaplastic lymphoma kinase (ALK) gene rearrangements in radiation-related human papillary thyroid carcinoma after the Chernobyl accident.
    Arndt A; Steinestel K; Rump A; Sroya M; Bogdanova T; Kovgan L; Port M; Abend M; Eder S
    J Pathol Clin Res; 2018 Jul; 4(3):175-183. PubMed ID: 29633575
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid cancer.
    Efanov AA; Brenner AV; Bogdanova TI; Kelly LM; Liu P; Little MP; Wald AI; Hatch M; Zurnadzy LY; Nikiforova MN; Drozdovitch V; Leeman-Neill R; Mabuchi K; Tronko MD; Chanock SJ; Nikiforov YE
    J Natl Cancer Inst; 2018 Apr; 110(4):371-378. PubMed ID: 29165687
    [TBL] [Abstract] [Full Text] [Related]  

  • 15.
    Bastos AU; de Jesus AC; Cerutti JM
    Eur J Endocrinol; 2018 Jan; 178(1):83-91. PubMed ID: 29046324
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Use of indocyanine green fluorescent angiography in a hyperbaric patient with soft tissue radiation necrosis: a case report.
    Johnson-Arbor K; Falola R; Kelty J; Barbour J; Attinger C
    Undersea Hyperb Med; 2017; 44(3):273-278. PubMed ID: 28779583
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid cancers of Young Patients in Fukushima.
    Iyama K; Matsuse M; Mitsutake N; Rogounovitch T; Saenko V; Suzuki K; Ashizawa M; Ookouchi C; Suzuki S; Mizunuma H; Fukushima T; Suzuki S; Yamashita S
    Thyroid; 2017 Jun; 27(6):811-818. PubMed ID: 28351223
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer.
    Park G; Kim TH; Lee HO; Lim JA; Won JK; Min HS; Lee KE; Park DJ; Park YJ; Park WY
    Endocr Relat Cancer; 2015 Feb; 22(1):55-63. PubMed ID: 25527510
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of the transforming strn-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer.
    Kelly LM; Barila G; Liu P; Evdokimova VN; Trivedi S; Panebianco F; Gandhi M; Carty SE; Hodak SP; Luo J; Dacic S; Yu YP; Nikiforova MN; Ferris RL; Altschuler DL; Nikiforov YE
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4233-8. PubMed ID: 24613930
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification of a recurrent strn/ALK fusion in thyroid carcinomas.
    Pérot G; Soubeyran I; Ribeiro A; Bonhomme B; Savagner F; Boutet-Bouzamondo N; Hostein I; Bonichon F; Godbert Y; Chibon F
    PLoS One; 2014; 9(1):e87170. PubMed ID: 24475247
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.